FAK-paxillin signaling and F-actin cytoskeletal organization Molecular Modulation of the NO-system, VEGFR2 signaling, growth-hormone receptor expression in fibroblasts, and interactions with dopamine- and serotonin-related neurotransmitter pathways Systemic (Preclinical) Rodent models of gastrointestinal mucosal lesions, liver injury, tendon and ligament transection, and vascular occlusion syndromes References (BPC-157): Sikiric P, et al
For individuals without insurance coverage, we offer self-pay options to ensure access to this beneficial treatment
Correcting Metabolic Disorders and Reducing Bodily Burden: Most myocardial infarction patients suffer from metabolic abnormalities such as obesity and insulin resistance
Compatible with most research peptides, including growth hormone secretagogues, metabolic peptides, and neuropeptides used in in-vitro laboratory applications
BPC-157 Pure oral spray The oral spray represents a different delivery strategy